D&D Pharmatech to acquire 10.9% of Z-Alpha Holdings for ₩10.0bn

D&D Pharmatech · KOSDAQ · 347850 · Nov 12, 2026 · Equity acquisitions and disposals

D&D Pharmatech Inc. filed to acquire 4,299,965 shares of Z-Alpha Holdings, Inc. (USA) for ₩10.0bn, equal to 10.9% of its equity. After the acquisition, the company's stake would be 4.8%, with the deal expected on Nov 16, 2026.

Key facts

Target companyZ-Alpha Holdings, Inc. (USA)
Shares4,299,965 shares
Deal amount₩10.0bn
% of equity10.9%
Stake after4.8%
PurposeStrengthening influence by participating in fundraising for a US alpha radiopharmaceutical therapy developer
Expected dateNov 16, 2026

Comparison

Amount as % of prior-year revenue (calculated)233.3%
Revenue 2025₩4.3bn
Revenue 2024₩11.4bn

Context

The filing gives the purpose as strengthening influence by participating in fundraising for a US alpha radiopharmaceutical therapy developer. By our calculation, the ₩10.0bn deal amount is 233.3% of prior-year revenue, and FY2025 revenue was ₩4.3bn.

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)